News

A team of researchers from The Scripps Research Institute (TSRI) and Janssen Research & Development has devised artificial peptide molecules that neutralize a broad range of influenza virus strains.

Scientists at the Institute for Protein Design have created a way to generate thousands of different mini-protein binders as possible drug candidates. The proteins can be custom tailored to specific therapeutic targets.

Oracle today announced that Celltrion, a global leading biopharmaceutical company, has selected Oracle Health Sciences Argus and Oracle Health Sciences Empirica Signal to streamline its pharmacovigilance case management and patient safety initiatives.

Researchers screened thousands of small molecules for potential drug candidates could improve memory and learning, and found a promising hit.

New data from three studies have demonstrated that the aerosol generated by Philip Morris International’s Carbon Heated Tobacco Product (CHTP) has a significantly reduced biological impact as compared with cigarette smoke.

Discovering potential therapeutic protein inhibitors for Chagas disease, through computational drug discovery and in vitro enzyme assays.

Outer membrane vesicles, biological nanoparticles shed during normal growth by bacteria, have seen significant recent advances in engineering and are thus finding new utility as therapeutic and drug delivery agents.

Explained placebos are still effective and suggests an ethical approach to administer them.

UCSB researchers compare the performance of human subjects versus deep neural networks in visual searches

A new technique that targets drugs to specific cells could lead to improved therapies for diseases caused by an overactive immune response.